NorthWest Biotherapeutics Inc (NWBO)

[GoodGuyBill]

Ex, So where in your quote does it say, "So now they should be able to handle about 200 patients a year" or "Advent is able to manufacture something like a 10-20 patients a year at Kings"? Where did you get the numbers.

The statement by Cognate was in a fairly recent interview from the CEO where he said they were maxed out in the DCVax-L trials. And now they are twice the size.

For several years, we were at capacity manufacturing product for one of the largest phase III clinical trials, providing products to nearly 90 clinical sites. We have since expanded twice, growing our capacity by more than four times. In fact, we’ve been taking on new clients since 2014 in preparation for the new capacity coming online and look forward to making more public appearances following our recapitalization and management-led buyout that we completed in Q1 2018.